Autoantibody to signal recognition particle in African American girls with juvenile polymyositis

Journal of Rheumatology

Volumn 35, Issue 5, 2008, Pages 927-929

  Rouster Stevens, Kelly A ^a   Pachman, Lauren M ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Anti signal recognition particle autoantibody; Juvenile polymyositis

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; SIGNAL RECOGNITION PARTICLE ANTIBODY; TACROLIMUS;

ADOLESCENT; AFRICAN AMERICAN; ARM WEAKNESS; ARTICLE; CASE REPORT; DISEASE CONTROL; DRUG DOSE INCREASE; ESOPHAGEAL DYSMOTILITY; ESOPHAGUS DISEASE; FEMALE; FLU LIKE SYNDROME; HEART LEFT VENTRICLE HYPERTROPHY; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTERSTITIAL LUNG DISEASE; MYOPATHY; OVARY INSUFFICIENCY; POLYMYOSITIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCHOOL CHILD;

ADOLESCENT; AFRICAN AMERICANS; AUTOANTIBODIES; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; POLYMYOSITIS; PROGNOSIS; SIGNAL RECOGNITION PARTICLE;

EID: 44349180409     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Mendez EP, Lipton R, Ramsey-Goldman R, et al. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases registry. Arthritis Rheum 2003;49:300-5.
2. Walter P, Blobel G. Purification of a membrane-associated protein complex required for protein translocation across the endoplasmic reticulum. Proc Natl Acad Sci USA 1980;77:7112-6.
3. Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990;33:1361-70.
4. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991;70:360-74.
5. Brouwer R, Hengstman GJ, Vree Egberts W, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001;60:116-23.
6. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 2004;50:209-15.
7. Chinoy H, Salway F, Fertig N, et al. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res Ther 2006;8:R13.
8. Miller T, Al-Lozi MT, Lopate G, Pestronk A. Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 2006;73:420-8.
9. Hengstman GJ, ter Laak HJ, Vree Egberts WT, et al. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 2006;65:1635-8.
10. Rider LG, Miller FW. Classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 1997;23:619-55.
11. O'Hanlon TP, Carrick DM, Targoff IN, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine 2006;85:111-27.
12. Leff RL, Burgess SH, Miller FW, et al. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum 1991;34:1391-6.
13. Tezak Z, Hoffman EP, Lutz JL, et al. Gene expression profiling in DQA1*0501 + children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 2002;103:260-3.
14. Pachman LM, Lipton R, Ramsey-Goldman R, et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Disease research registry. Arthritis Rheum 2005;15:166-72.